Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
BlackRock, Inc. reported a 15.60% stake in Ligand Pharmaceuticals Incorporated (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 15.60% stake in Ligand Pharmaceuticals Incorporated, 2,945,939 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 15.60%
- Shares
- 2,945,939
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 15.60% | 2,945,939 |
Source
Related
- Ligand Pharmaceuticals Incorporated
- BlackRock, Inc.
- Ligand Pharmaceuticals Incorporated shareholders
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026